Compare Cipta Sarana Medika Tbk. (DKHH) vs Chandra Asri Pacific Tbk. (TPIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cipta Sarana Medika Tbk. vs Chandra Asri Pacific Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 160.67B), while Chandra Asri Pacific Tbk. trades at Rp1,910 (market cap 165.24T). The key difference: Chandra Asri Pacific Tbk. is far larger — about 1028.4× Cipta Sarana Medika Tbk.'s market cap. Which is the better fit depends on your goals.
| DKHH | TPIA | |
|---|---|---|
Market Cap | 160.67B | 165.24T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →About Chandra Asri Pacific Tbk.
PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →
